Otsuka Pharmaceutical Co. Ltd. v. Apotex Inc.
1:15-cv-00109
Overview
Parties
Defendant
Apotex Corp. Operating Company
Represented By
3 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Apotex Inc. Operating Company
Represented By
2 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Plaintiff
Otsuka Pharmaceutical Co. Ltd. Operating Company
Represented By
6 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 11 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 5,753,677 A Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 5,985,869 A | US Continuation / Sibling | View Official Patent → |
| π―π΅ Japan | JP 27433889 | Japan Counterpart | View Official Patent → |
| π―π΅ Japan | JP 18185890 | Japan Counterpart | View Official Patent → |
| π PCT International (WIPO) | WO 1991005549 A1 | PCT World Application | View Official Patent → |
| π―π΅ Japan | JP 3182066 A | Japan Counterpart | View Official Patent → |
| π―π΅ Japan | JP 2905909 B2 | Japan Counterpart | View Official Patent → |
| πΊπΈ United States | US 76,201,591 A | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 851541 A | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 5,258,510 A | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 5,559,230 A | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5753677
Benzoheterocyclic compounds
|
Filed: 1995-06-07
Issued: 1998-05-19
|
Expired (Term Ended)
+1808d PTA
Expires: 2020-05-19
|
|
|
US8501730
Process for preparing benzazepine compounds or salts thereof
|
Filed: 2012-05-17
Issued: 2013-08-06
|
Active (5.5 yrs remaining)
Expires: 2032-05-17
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
High PTA (+1808 days) / Cellect Scrutiny β Over 1808 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
1
Dispositive
0
Granted
0
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings